Immutep Ltd banner

Immutep Ltd
NASDAQ:IMMP

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
NASDAQ:IMMP
Watchlist
Price: 2.72 USD 3.03% Market Closed
Market Cap: $395.1m

Profitability Summary

Immutep Ltd's profitability score is 17/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score
17/100
Profitability
Score

Margins

Earnings Waterfall
Immutep Ltd

Margins Comparison
Immutep Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
AU
Immutep Ltd
ASX:IMM
579.8m AUD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
411.5B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
201.1B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
192.5B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.8B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.8B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
73.9B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Immutep Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Immutep Ltd
ASX:IMM
579.8m AUD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
411.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
201.1B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
192.5B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.8B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.8B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
73.9B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Immutep Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate